Paul McCormac - Chief Technical Officer at Lexeo Therapeutics, Inc.

Issuer-level insider activity

Role
Chief Technical Officer
Issuer ticker
LXEO on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Paul McCormac since 21 Sep 2025

Reported holdings for Paul McCormac in Lexeo Therapeutics, Inc.

Form 4 holding Chief Technical Officer

Lexeo Therapeutics, Inc.

Security class
Common Stock
Shares / value
17,349
Estimated value
$229,329
Report date
07 Nov 2023
Price
$13.22
Ownership
Direct
Form 4 holding Chief Technical Officer

Lexeo Therapeutics, Inc.

Security class
Series B convertible preferred stock
Shares / value
0
Estimated value
Report date
07 Nov 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Paul McCormac in Lexeo Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .